The maker of the newest treatment approved for amyotrophic lateral sclerosis said Thursday that it would withdraw the drug from the market because a large clinical trial did not produce evidence that the treatment worked. The company, Amylyx Pharmaceuticals, said in a statement that it had started the process of withdrawing the drug in the […]
Read More